LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹166 Cr | ₹162 Cr | ₹136 Cr | ₹116 Cr | ₹113 Cr |
What is the latest Sundry Debtors ratio of LINCOLN PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹166 Cr |
| Mar2024 | ₹162 Cr |
| Mar2023 | ₹136 Cr |
| Mar2022 | ₹116 Cr |
| Mar2021 | ₹113 Cr |
How is Sundry Debtors of LINCOLN PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹166 Cr | 2.86 | |
| Mar2024 | ₹162 Cr | 18.66 | |
| Mar2023 | ₹136 Cr | 17.59 | |
| Mar2022 | ₹116 Cr | 2.29 | |
| Mar2021 | ₹113 Cr | - | |
Compare Sundry Debtors of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,144.1 Cr | -1.7% | -7.9% | 5.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹480,047.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹208,141.0 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,264.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| CIPLA | ₹118,430.0 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,516.1 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -1.7% |
-7.9% |
5.7% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses